PWM
Palumbo Wealth Management Portfolio holdings
AUM
$323M
This Quarter Return
+1.21%
1 Year Return
+22.5%
3 Year Return
+55.87%
5 Year Return
–
10 Year Return
–
AUM
$299M
AUM Growth
+$299M
(+12%)
Cap. Flow
+$31.9M
Cap. Flow
% of AUM
10.65%
Top 10 Holdings %
Top 10 Hldgs %
39.82%
Holding
199
New
24
Increased
127
Reduced
28
Closed
12
Top Buys
| 1 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
$2.05M |
| 2 |
Apple
AAPL
|
$1.63M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
$1.53M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$1.45M |
| 5 |
NVIDIA
NVDA
|
$1.4M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$3.62M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$1.22M |
| 3 |
GeneDx Holdings
WGS
|
$638K |
| 4 |
CrowdStrike
CRWD
|
$407K |
| 5 |
ServiceNow
NOW
|
$296K |
Sector Composition
| 1 | Technology | 15.17% |
| 2 | Healthcare | 8.12% |
| 3 | Financials | 7.99% |
| 4 | Consumer Discretionary | 7.11% |
| 5 | Industrials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
VanEck Gold Miners ETF
GDX
$19.6B
| $249K | 0.08% |
+5,416
| New | +$249K |
|
152
Cisco
CSCO
$268B
| $242K | 0.08% |
+3,926
| New | +$242K |
|
153
Mirum Pharmaceuticals
MIRM
$3.75B
| $242K | 0.08% |
+5,376
| New | +$242K |
|
154
3M
MMM
$81B
| $239K | 0.08% |
+1,631
| New | +$239K |
|
155
Marsh & McLennan
MMC
$101B
| $233K | 0.08% |
+953
| New | +$233K |
|
156
Ecolab
ECL
$77.5B
| $229K | 0.08% |
902
+43
| +5% | +$10.9K |
|
157
Reddit
RDDT
$41.8B
| $226K | 0.08% |
2,158
+507
| +31% | +$53.2K |
|
158
Stryker
SYK
$149B
| $225K | 0.08% |
+605
| New | +$225K |
|
159
Design Therapeutics
DSGN
$339M
| $225K | 0.08% |
58,278
+3,582
| +7% | +$13.8K |
|
160
Pharvaris
PHVS
$1.41B
| $221K | 0.07% |
14,102
+3,881
| +38% | +$60.9K |
|
161
Treace Medical Concepts
TMCI
$458M
| $216K | 0.07% |
25,690
+3,431
| +15% | +$28.8K |
|
162
National Fuel Gas
NFG
$7.77B
| $211K | 0.07% |
+2,670
| New | +$211K |
|
163
Roku
ROKU
$14.5B
| $206K | 0.07% |
+2,925
| New | +$206K |
|
164
Zai Lab
ZLAB
$3.48B
| $203K | 0.07% |
+5,612
| New | +$203K |
|
165
Nuvation Bio
NUVB
$1.08B
| $193K | 0.06% |
109,643
+44,283
| +68% | +$77.9K |
|
166
Butterfly Network
BFLY
$378M
| $193K | 0.06% |
84,618
+11,248
| +15% | +$25.6K |
|
167
Prime Medicine
PRME
$595M
| $190K | 0.06% |
+95,462
| New | +$190K |
|
168
MiMedx Group
MDXG
$1.05B
| $181K | 0.06% |
23,765
+5,980
| +34% | +$45.4K |
|
169
Seer Inc
SEER
$114M
| $177K | 0.06% |
104,754
-3,393
| -3% | -$5.73K |
|
170
Arbor Realty Trust
ABR
$2.28B
| $176K | 0.06% |
14,950
+502
| +3% | +$5.9K |
|
171
Assembly Biosciences
ASMB
$183M
| $172K | 0.06% |
17,986
+6,559
| +57% | +$62.7K |
|
172
Organogenesis Holdings
ORGO
$629M
| $167K | 0.06% |
38,666
+18,476
| +92% | +$79.8K |
|
173
UiPath
PATH
$5.82B
| $165K | 0.06% |
15,982
+4,645
| +41% | +$47.8K |
|
174
GH Research
GHRS
$870M
| $142K | 0.05% |
+12,869
| New | +$142K |
|
175
Ardelyx
ARDX
$1.57B
| $136K | 0.05% |
27,638
+10,597
| +62% | +$52K |
|